KIDS

OrthoPediatrics Corp.

Healthcare · $579M market cap

Verdict

We can't put a fair value on KIDS right now. It has lost money in each of its last 3 years, and our valuation needs recent profits to project from.

Business quality

1 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth—?
Equity per share growth9.6% a year✗
Sales growth22.8% a year✓
Free cash flow growth—?
Return on invested capital-6.3%✗

Follow KIDS

Track it on your watchlist and see the full analysis. Free.

Create a free account

Insider activity

Since Sep 2, 2026: no open-market purchases and 6 sales worth $20.6M. Why purchases matter

Sales

About OrthoPediatrics Corp.

OrthoPediatrics Corp. is a medical technology firm dedicated to the design, development, and global commercialization of specialized implants and devices. These products are meticulously crafted to be anatomically appropriate for treating children affected by orthopedic conditions across the United States and internationally. The company's diverse offerings span products for trauma and deformity correction, surgical…

Medical - Devices

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works

KIDS stock (OrthoPediatrics Corp.): ownership and insider trades — PaybackPrice